Klonbiyotek Biotechnology is actively seeking strategic partnerships to expand our product portfolio, enter new markets, and leverage our technological platform. We are interested in the following types of collaboration:
Contract Development and Manufacturing Organization (CDMO) Services: We offer our expertise to partners for the custom development and production of veterinary rapid tests. This includes utilizing our antibodies or integrating customer-provided reagents into a lateral flow format.
Out-licensing of Antibodies & Technology: We are open to licensing our proprietary monoclonal and polyclonal antibodies to diagnostic companies or research institutions for use in their own assay development.
Research & Development Partnerships: We seek to collaborate on joint research projects, particularly in:
-Developing new rapid tests for emerging or neglected veterinary diseases.
-Improving lateral flow technology for higher sensitivity and multiplexing capabilities.
-Creating species-specific antibody panels for research and diagnostic use.
Commercial Distribution Agreements: We are interested in partnering with established distributors to bring our portfolio of veterinary rapid diagnostic kits to markets outside of Turkey.

Target Partners
We are looking to collaborate with:
Veterinary pharmaceutical and diagnostic companies.
Research institutions and universities working in animal health.
Agribusiness and animal production companies requiring on-site health monitoring tools.
Distributors specializing in veterinary diagnostics.

1. Company Profile
Company Name: Klonbiyotek Biotechnology
Type of Organization: Small-Medium Enterprise (SME)
Location: Kayseri, Turkey
Core Business: Development and production of rapid diagnostic kits and antibody technologies for veterinary medicine.

2. Areas of Expertise & Core Competencies
Klonbiyotek Biotechnology possesses specialized, in-house expertise across the entire value chain of veterinary immunodiagnostics:
Rapid Diagnostic Kit Production: We specialize in the development and large-scale manufacturing of Lateral Flow Immunochromatography-based rapid tests for veterinary applications. This includes tests for infectious diseases, biomarkers, and health status monitoring in various animal species.
Antibody Development & Purification: Our team has proven expertise in the full cycle of antibody generation, including:
Monoclonal Antibody (mAb) Development: Hybridoma technology, screening, and cloning.
Polyclonal Antibody (pAb) Development: Immunization protocols in host animals (e.g., rabbit, goat, chicken) and antiserum processing.
Antibody Purification: Protein A/G affinity chromatography, antigen-specific purification, and fragmentation (e.g., Fab, F(ab')2) to ensure high-quality reagents for kit integration.

3. Fields of Activity & Technologies
Our primary technological platform is Lateral Flow Immunochromatography, a well-established, cost-effective, and user-friendly format for point-of-care testing. We combine this platform with our internally developed and purified antibodies to create highly specific and sensitive diagnostic solutions for the veterinary market. Our activities span from initial concept and feasibility studies to pilot production and scale-up for commercial distribution.